About Us
The Health Thread
Ethical Health Journalism
Live
🌍Urgent Alert: Deano's Pasta Recalls Ravioli Over Hidden Lobster Allergen Risk🌍Saratoga Chips Recall: Undeclared Soy Poses Allergy Risk🌍So Delicious Dairy-Free Frozen Dessert Recall: What Consumers Need to Know About Food Safety🌍Hidden Egg Allergen Prompts Whole Foods Cheese Recall🌍DR Congo Camp Residents Face Dire Conditions, Violence, and Ebola Threat🌍Urgent Alert: Deano's Pasta Recalls Ravioli Over Hidden Lobster Allergen Risk🌍Saratoga Chips Recall: Undeclared Soy Poses Allergy Risk🌍So Delicious Dairy-Free Frozen Dessert Recall: What Consumers Need to Know About Food Safety🌍Hidden Egg Allergen Prompts Whole Foods Cheese Recall🌍DR Congo Camp Residents Face Dire Conditions, Violence, and Ebola Threat
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

[Telemonitoring in Oncology: A French overview between 2022 and 2025].

Researchers

Emma Di Méglio, Mélina Hocine, Emmanuel Coget, Pascale Brouard, Christelle Cousin, Clément Carbasse, Frédéric Fiteni

Abstract

In oncology, telemonitoring symptoms of patients has shown significant benefits in terms of overall survival and quality of life in several clinical trials in oncology. Telemonitoring has been reimbursed in France since 2023. Our study aims to establish a French overview of telemonitoring in oncology between 2022 and 2025. In 2022, 113 pharmacists in cancer departments authorized to produce chemotherapy in France, and then 78 in 2025, completed an electronic form about their use of telemonitoring in their departments. Among the responding centres, 12.61% used telemonitoring in oncology in 2022 versus 35.90% in 2025. These centers described similar obstacles to the implementation of these platforms in both studies, such as lack of interoperability, limitation on patient use, lack of human resources and clinician engagement. Since their reimbursement in 2023, telemonitoring platforms in French cancer departments has been developed, but difficulties persist in routine practice, due to a lack of resources for professionals. This requires better training for professionals and optimization of the platform by developers.
Source: PubMed (PMID: 42816284)View Original on PubMed